Motiva® SmoothSilk® Round Breast Implant RSF-335+Recalls & reported problems
Establishment Labs S.A. · Motiva® SmoothSilk® Round Breast Implant Round Breast Implant - Full 335 cc · Class 3 · Implant
All models of Motiva SmoothSilk Round Breast Implant (53)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 07445161002099), received between Nov 14, 2024 and Nov 6, 2025 — classified as 5 injuries.
The most frequently reported specific device problem is “Break” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break4
- Adverse Event Without Identified Device or Use Problem1
- Device Appears to Trigger Rejection1
Patient problems
- Insufficient Information3
- Breast Discomfort/Pain2
- Ptosis2
- Discomfort1
- Impaired Healing1
- Pain1
- Unspecified Infection1
- Wound Dehiscence1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryNov 6, 2025Device Appears to Trigger Rejection; Adverse Event Without Identified Device or Use Problem; Device Appears to Trigger Rejection; Adverse Event Without Identified Device or Use Problem
USA. ALLEGEDLY, A PATIENT WHO HAD AN AUGMENTATION MAMMOPLASTY IN (B)(6) 2025 DEVELOPED A POSTOPERATIVE WOUND INFECTION, FOLLOWED BY WOUND DEHISCENCE AND IMPLANT EXPOSURE ON HER RIGHT BREAST. THE SURGEON REPORTS THAT HE PRESCRIBED ORAL ANTIBIOTICS A FEW DAYS AFTER THE SURGERY, AS THE PATIENT REPORTED THAT SHE WENT SWIMMING IN A POOL. SHE UNDERWENT A DELAYED WOUND CLOSURE 24 DAYS AFTER SURGERY, AS A SUPERFICIAL WOUND DEHISCENCE WAS FOUND. THE PATIENT RESUMED PHYSICAL ACTIVITY PREMATURELY AND ADMITTED INCONSISTENT ADHERENCE TO THE POSTOPERATIVE RESTRICTIONS. WHEN SHE WENT BACK TO EVALUATION IN (B)(6) 2025, AN IMPLANT EXPOSURE WAS VISIBLE. REVISION SURGERY IS REQUIRED. NO PATIENT DEMOGRAPHICS, SUCH AS WEIGHT, OR ETHNICITY, WERE PROVIDED BY THE REPORTER. EFFORTS TO GATHER ADDITIONAL INFORMATION ARE ONGOING, AND THE INVESTIGATION REMAINS IN PROGRESS.
Patient problems: Impaired Healing; Unspecified Infection; Wound Dehiscence
MAUDE report 23490485 ↗InjuryNov 6, 2025Break; Break
SOUTH AFRICA. ALLEGEDLY, A RENT IN THE IMPLANT AT THE INFERIOR POLE WAS DETECTED DURING A MAMMOGRAM (SN: (B)(6)). A REVISION SURGERY WAS PERFORMED. NO PATIENT DEMOGRAPHICS, SUCH AS WEIGHT, OR ETHNICITY, WERE PROVIDED BY THE REPORTER. EFFORTS TO GATHER ADDITIONAL INFORMATION ARE ONGOING, AND THE INVESTIGATION REMAINS IN PROGRESS.
Patient problems: Insufficient Information
MAUDE report 23486456 ↗InjuryAug 29, 2025Break; Break
SOUTH AFRICA. IT WAS REPORTED THAT A PATIENT WHO HAD MOTIVA IMPLANTS IN (B)(6) 2024, PRESENTED PAIN AND DISPLACEMENET (MALPOSITION) AND WAS DIAGNOSED WITH AN INTRACAPSULAR AND EXTRACAPSULAR RUPTURE IN BOTH BREASTS. NO PATIENT DEMOGRAPHICS, SUCH AS WEIGHT, OR ETHNICITY, WERE PROVIDED BY THE REPORTER. EFFORTS TO GATHER ADDITIONAL INFORMATION ARE ONGOING, AND THE INVESTIGATION REMAINS IN PROGRESS.
Patient problems: Breast Discomfort/Pain; Insufficient Information; Ptosis
MAUDE report 22923864 ↗InjuryAug 29, 2025Break; Break
SOUTH AFRICA. IT WAS REPORTED THAT A PATIENT WHO HAD MOTIVA IMPLANTS IN (B)(6) 2024, PRESENTED PAIN AND DISPLACEMENT (MALPOSITION) AND WAS DIAGNOSED WITH AN INTRACAPSULAR AND EXTRACAPSULAR RUPTURE IN BOTH BREASTS. NO PATIENT DEMOGRAPHICS, SUCH AS WEIGHT, OR ETHNICITY, WERE PROVIDED BY THE REPORTER. EFFORTS TO GATHER ADDITIONAL INFORMATION ARE ONGOING, AND THE INVESTIGATION REMAINS IN PROGRESS.
Patient problems: Breast Discomfort/Pain; Insufficient Information; Ptosis
MAUDE report 22923860 ↗InjuryNov 14, 2024Break; Break
THE PATIENT'S PRIMARY AUGMENTATION WAS PERFORMED IN 2016. AFTER 8 YEARS, THE PATIENT BEGAN TO FEEL PAIN AND DISCOMFORT IN THE CHEST AREA. THE MRI CONCLUSION CONFIRMED A LEFT IMPLANT RUPTURE. NO PATIENT DEMOGRAPHICS, SUCH AS AGE, WEIGHT, OR ETHNICITY, WERE PROVIDED BY THE REPORTER, AND NO ADVERSE OUTCOMES FOR THE PATIENT HAVE BEEN NOTED. EFFORTS TO GATHER ADDITIONAL INFORMATION ARE ONGOING, AND THE INVESTIGATION REMAINS IN PROGRESS.
Patient problems: Discomfort; Pain
MAUDE report 20689170 ↗
Other Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices
- MENTOR MemoryGel Breast Implant 3503501BCMentor Texas L.P. · Prosthesis, breast, noninflatable, internal, silicone gel-filled2,167 reports
- MENTOR MemoryGel Breast Implant 3504001BCMentor Texas L.P. · Prosthesis, breast, noninflatable, internal, silicone gel-filled2,130 reports
- MENTOR MemoryGel Breast Implant 3504004BCMentor Texas L.P. · Prosthesis, breast, noninflatable, internal, silicone gel-filled2,012 reports
- MENTOR MemoryGel Breast Implant 3504504BCMentor Texas L.P. · Prosthesis, breast, noninflatable, internal, silicone gel-filled1,754 reports
- MENTOR MemoryGel Breast Implant 3503001BCMentor Texas L.P. · Prosthesis, breast, noninflatable, internal, silicone gel-filled1,752 reports
- MENTOR MemoryGel Breast Implant 3503504BCMentor Texas L.P. · Prosthesis, breast, noninflatable, internal, silicone gel-filled1,749 reports
- MENTOR MemoryGel Breast Implant 3504501BCMentor Texas L.P. · Prosthesis, breast, noninflatable, internal, silicone gel-filled1,690 reports
- MENTOR MemoryGel Breast Implant 3503251BCMentor Texas L.P. · Prosthesis, breast, noninflatable, internal, silicone gel-filled1,684 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page